CLINICAL_TRIALS
trial_result
· 2013-07-18
Clinical Trial Update: A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZE [Phase 4]
Summary
Phase 4 trial evaluating escalating doses of CINRYZE for hereditary angioedema has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shire | Conditions: Hereditary Angioedema | Phase 4 | Status: COMPLETED | Results posted: 2013-07-18